GlobeNewswire Inc.··Medicinova, Inc.Study Validates MediciNova's Brain Metastasis Drug as Cancer Research Advances
MediciNova's drug candidate gains validation in peer-reviewed Cancer Research study, with CNIO identifying MIF signaling as brain metastasis target and potential CSF biomarker for patient stratification.
MNOVbiomarkerbrain metastasis